MoneyWorks4Me

Alkem Laboratories informs about analyst meet

26 Jul 2022 Evaluate
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed that a conference call to discuss the Q1FY23 financial results will be held on Friday, 05th August, 2022 at 04.00 pm. 

The above information is a part of company’s filings submitted to BSE.


Alkem Laboratories Share Price

5257.00 -43.00 (-0.81%)
02-Sep-2026 09:23 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1936.50
Dr. Reddys Labs. 1169.50
Cipla 1407.00
Lupin 2148.00
Zydus Lifesciences 1164.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: